Skip to main content
Signal8

NUTRA PHARMA CORP (NPHC)

Nutra Pharma Corp. (NPHC) operates as a biopharmaceutical firm specializing in obtaining, licensing, and bringing to market a variety of pharmaceutical products, cutting-edge technologies, and both homeopathic and ethical medications. The company primarily targets the U.S. market, focusing its efforts on managing conditions such as pain, neurological ailments, cancer, autoimmune diseases, and infectious diseases. Its current commercial offerings include: Nyloxin and Nyloxin Extra Strength: These products are distributed as an oral spray for alleviating lower back pain, migraines, neck and shoulder discomfort, cramps, and neuropathic pain, and as a topical gel to relieve joint pain, arthritis, and repetitive stress injuries. Pet Pain-Away: An over-the-counter (OTC) homeopathic, non-narcotic, and non-addictive solution for chronic pain in household pets. Luxury Feet: An OTC pain reliever and anti-inflammatory designed to ease foot pain or discomfort specifically caused by high heels and stilettos. Nyloxin Military Strength: A specialized formulation for pain relief aimed at the United States Military and Veteran's Administration. Equine Pain-Away: An OTC topical pain management product for horses. Beyond its existing portfolio, Nutra Pharma Corp. is also advancing several pipeline candidates: RPI-78M: In development to treat neurological conditions such as multiple sclerosis, adrenomyeloneuropathy, and amyotrophic lateral sclerosis, alongside autoimmune diseases like rheumatoid arthritis and myasthenia gravis. RPI-MN: Under investigation for viral diseases, including human immunodeficiency virus (HIV/AIDS) and herpes, as well as for general antiviral applications. RPI-78: Being developed for applications in pain and arthritis. RPI-70: Also in development for pain relief. Founded in 2000, the company is headquartered in Plantation, Florida.

Sector: Medicinal Chemicals & Botanical Products

Industry: Drug Manufacturers - Specialty & Generic

Nutra Pharma Corp. logo

Nutra Pharma Corp.

OTC:NPHCHealthcare
$0.0001
Mkt Cap$716K
Float7.09B
O/S7.16B
Inst Own0.0%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$385K
Net Income-$2.05M
Total Assets$585K
Free Cash Flow-$1.19M
Debt & Equity
Total Debt$9.76M
Total Equity-$16.83M
Preferred Stock$12K
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
  1. 1:40Reverse split
    May 18, 201540 shares → 1
Balance Sheet Details
Assets$585K
Liabilities$17.41M
Accounts Receivable$375K
Accounts Payable$854K
Inventory$20K
PP&E (Net)$26K
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006FY 2005FY 2004FY 2003FY 2002FY 2001FY 2000
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
Revenue$385K$438K$98K$52K$104K$131K$121K$168K$291K$595K$122K$203K$160K$1.43M$618K$4K$0$20K$0$0$0$0$0$86
YoY Growth-12.1%348.4%88.3%-50.3%-20.1%7.9%-28.1%-42.2%-51.0%386.5%-39.9%27.4%-88.9%131.7%15178.4%---------
Cost of Revenue$189K$189K$89K$37K$70K$117K$27K$223K$66K$114K$41K$148K$880K$617K$279K$1K$0$3K$0$0$0$0$0$0
Gross Profit$197K$249K$8K$15K$35K$14K$94K-$55K$225K$480K$81K$56K-$720K$815K$339K$3K$0$17K$0$0$0$0$0$86
Gross Margin51.0%56.8%8.7%28.7%33.3%10.8%77.8%-32.5%77.4%80.8%66.3%27.4%-451.1%56.9%54.9%73.9%-82.8%-----100.0%
Research and Development$0$0$0$0$0$0$0$0$0$0$0$3K$91K$192K$223K$0$0$411K$224K$1.1M$0$0$0$0
Selling, General, and Administrative$1.61M$2.16M$1.93M$1.1M$1.2M$1.39M$1.48M$1.99M$5.99M$2.68M$2.44M$2.65M$3.04M$3.95M$2.2M$1.71M$1.17M$1.99M$4.42M$989K$1.64M$27K$68K$2K
Other$53K$0$0$0$0$0$0$19K$28K$0$0$0$100K$0$0$0$0$0$0$550K$107K-$117K$117K$0
Total Operating Expenses$1.66M$2.16M$1.93M$1.1M$1.2M$1.39M$1.48M$1.99M$5.99M$2.68M$2.44M$2.66M$3.23M$4.14M$2.42M$1.71M$1.17M$2.4M$4.65M$2.64M$1.74M-$89K$184K$2K
Operating Income (EBIT)-$1.46M-$1.91M-$1.92M-$925K-$1.17M-$1.88M-$1.38M$2.04M$5.77M$2.2M$2.36M$2.6M-$3.95M$3.4M-$2.08M$1.71M$1.17M$2.39M$4.65M$2.64M$1.74M$89K$68K$2K
Operating Margin-379.5%-435.2%-1964.6%-1782.3%-1118.9%-1438.7%-1142.3%1213.8%1979.4%370.4%1932.5%1279.5%-2475.3%237.2%-337.0%42195.4%-11809.8%-----2267.4%
Interest Expense$440K$791K$496K$336K$262K$590K$359K$294K$435K$128K$157K$153K$424K$74K$69K$58K$76K$46K$270K$5K$0$0$0$0
Interest Income$59K$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Income (Expense)-$585K$10.08M-$11.11M$156K-$5.36M-$2.01M-$2.65M-$1.4M$374K-$331K-$1.98M-$1.01M-$23K$261K-$219K-$2.46M$1.01M-$7K-$505K-$2.43M-$2.08M$0-$68K-$2K
Income Before Tax (EBT)-$2.05M$8.18M-$13.1M-$769K-$6.59M-$3.88M-$4.03M-$3.45M-$5.39M-$2.53M-$4.34M-$3.61M-$3.97M$3.73M-$2.23M-$4.16M-$165K-$2.43M-$5.15M-$7.94M-$2.78M$0$0$0
Income Tax Expense$0$0$0$0$0$0$0$313K$462K$128K$157K$153K$447K-$261K$219K$2.46M$2.42M-$4.77M$505K$43K-$43K$0$252K$4K
Net Income-$2.05M$8.18M-$13.1M-$769K-$6.59M-$3.88M-$4.03M-$3.45M-$5.39M-$2.53M-$4.34M-$3.61M-$4.4M-$3.06M-$2.3M-$4.16M-$165K-$2.43M-$5.15M-$7.99M-$2.74M$89K-$184K-$2K
Net Income Margin-531.4%1865.7%-13399.0%-1482.1%-6314.1%-2974.6%-3330.1%-2047.8%-1851.0%-426.1%-3554.0%-1776.9%-2755.2%-213.8%-372.4%-102895.1%--12035.5%------2267.4%
Supplementary Data
EPS-0.000.00-0.00-0.00-0.00-0.00-0.00-0.02-0.10-0.08-0.40-0.40-0.40-0.40-0.40-1.20-0.09-1.20-3.20-6.40-2.830.09-0.17-0.00
Diluted EPS-0.000.00-0.00-0.00-0.00-0.00-0.00-0.02-0.10-0.08-0.23-0.36-0.59-0.45-0.40-1.01-0.09-1.36-3.20-6.27-2.830.09-0.17-0.00
Weighted Average OS7.78B19.10B7.23B6.61B4.71B3.19B1.05B168.46M55.60M30.64M18.59M10.07M7.44M6.88M5.76M4.12M1.93M1.79M1.61M1.27M966,727952,2601.11M1.11M
EBITDA-$1.36M-$1.79M-$12.54M-$366K-$6.25M-$3.29M-$3.66M-$3.15M-$4.95M-$2.39M-$4.17M-$3.44M-$3.96M-$3.31M-$2.08M-$4.1M-$66K-$2.36M-$4.85M-$7.38M-$596K-$27K-$184K-$2K
EBITDA Margin-353.2%-408.6%-12827.0%-704.6%-5988.9%-2518.2%-3028.5%-1868.1%-1698.0%-401.7%-3413.0%-1694.1%-2479.4%-230.9%-336.0%-101314.2%--11697.7%------2167.4%
Balance Sheet
PeriodFY 2025FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006FY 2005FY 2004FY 2003FY 2002FY 2001
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
Assets
Current Assets
Cash and Cash Equivalents$12K$0$91K-$143K-$217K$0$0$31K$7K$16K$5K$8K$0$0$803K$51K$123K$19K$69K$409K$47K$0$0
Short-Term Investments$18K$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$30K$0$91K-$143K-$217K$0$0$31K$7K$16K$5K$8K$0$0$803K$51K$123K$19K$69K$409K$47K$0$0
Accounts Receivable$375K$22K$325K$40K$32K$17K$285K$31K$22K$127K$11K$38K$8K$244K$240K$0$0$0$0$0$0$819K$0
Inventory$20K$24K$31K$5K$8K$35K$20K$26K$54K$47K$5K$0$118K$253K$166K$11K$11K$11K$0$0$0$0$0
Other Current Assets$0$225K$0$143K$225K$63K$0$98K$267K$152K$68K$201K$0$0$0$0$0$0$0$0$0$0$0
Total Current Assets$460K$334K$534K$55K$58K$115K$358K$185K$349K$342K$89K$247K$158K$638K$1.23M$89K$134K$30K$69K$409K$47K$819K$0
Long-Term Assets
Property, Plant & Equipment Net$26K$332K$139K$159K$214K$11K$16K$14K$19K$29K$25K$40K$55K$69K$12K$10K$0$38K$51K$59K$0$0$0
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$4.39M$0$1.63M
Long-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$517K$0$0
Other Long-Term Assets$99K$89K$108K$88K$68K$16K$16K$16K$19K$16K$16K$17K$17K$47K$9K$8K$10K$37K$15K$125K-$517K$0$0
Total Long-Term Assets$125K$421K$246K$246K$282K$26K$32K$29K$38K$45K$40K$56K$71K$116K$21K$18K$10K$75K$66K$184K$4.39M$0$1.63M
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$585K$755K$780K$302K$340K$141K$390K$214K$388K$387K$129K$303K$229K$753K$1.25M$107K$144K$106K$135K$594K$4.44M$819K$1.63M
Liabilities
Current Liabilities
Accounts Payable$854K$727K$672K$599K$583K$475K$393K$958K$842K$1.24M$1.02M$801K$1.1M$711K$104K$156K$22K$154K$159K$144K$141K$0$0
Short-Term Debt$9.62M$8.05M$7.6M$4.64M$7.35M$3.53M$3.47M$2.63M$1.64M$1.5M$2.05M$1.37M$1.21M$305K$80K$100K$100K$1.35M$238K$207K$0$0$0
Current Income Tax Payable$0$0$216K$216K$168K$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$2.25M$201K$123K$2.02M$22K$1.01M$1.13M$1.02M$958K$1.69M$0$0$0$850K$0$461K$0$0$0$0$0
Other Current Liabilities$6.8M$811K$9.27M$3.57M$1.41M$122K$6K$49K$143K$187K$323K$742K$0$1.21M$1.25M$1.56M$1.94M$0$0$0$287K$862K-$1.68M
Total Current Liabilities$17.27M$12.7M$21.14M$11.48M$10.99M$6.03M$5.8M$4.65M$3.75M$3.95M$4.35M$3.88M$4.11M$3.17M$2.4M$2.66M$2.1M$1.97M$794K$547K$435K$864K$43K
Long-Term Liabilities
Long-Term Debt$137K$254K$517K$253K$908K$51K$0$3K$61K$30K$0$0$0$0$0$0$0$0$0$0$0$0$43K
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$517K$0$0
Other Long-Term Liabilities$0$0$0$0$0$0$0$39K$147K$0$0$0$0$110K$0$0$0$0$0$0$0$0-$43K
Total Long-Term Liabilities$137K$432K$517K$313K$1.05M$51K$0$42K$208K$30K$0$0$29K$110K$0$0$0$0$0$0$517K$0$1.73M
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$17.41M$13.13M$21.66M$11.8M$12.04M$6.08M$5.8M$4.69M$3.96M$3.98M$4.35M$3.88M$4.14M$3.28M$2.4M$2.66M$2.1M$1.97M$794K$547K$952K$864K$1.77M
Stockholders' Equity
Preferred Stock$12K$12K$12K$3K$3K$3K$3K$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Common Stock$7.1M$7.04M$7.33M$6.96M$5.88M$4.05M$2.03M$295K$80K$1.47M$1M$562K$321K$280K$270K$211K$82K$73K$69K$54K$48K$44K$69K
Retained Earnings-$78.28M-$73.55M-$81.73M-$68.63M-$67.86M-$61.27M-$57.39M-$53.36M-$49.91M-$44.52M-$41.99M-$37.64M-$34.03M-$29.63M-$26.57M-$24.27M-$20.11M-$19.94M-$17.51M-$12.36M-$4.3M-$96K-$186K
Comprehensive Income & Other$502K$470K$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0-$686$0
Other Stockholders' Equity$54.35M$54.13M$53.52M$50.18M$50.29M$51.29M$49.95M$48.59M$46.26M$39.45M$36.76M$33.51M$29.8M$26.83M$25.16M$21.5M$18.07M$18.01M$16.78M$12.35M$7.74M$7K-$18K
Total Equity-$16.83M-$12.38M-$20.88M-$11.49M-$11.7M-$5.94M-$5.41M-$4.48M-$3.57M-$3.59M-$4.22M-$3.58M-$3.91M-$2.53M-$1.14M-$2.56M-$1.95M-$1.86M-$659K$47K$3.49M-$45K-$134K
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$585K$755K$780K$302K$340K$141K$390K$214K$388K$387K$129K$303K$229K$753K$1.25M$107K$144K$106K$135K$594K$4.44M$819K$1.63M
Supplementary Data
Total Debt$9.76M$8.55M$8.2M$5.04M$8.48M$3.58M$3.47M$2.63M$1.7M$1.53M$2.05M$1.37M$1.21M$334K$80K$100K$0$100K$238K$207K$0$0$43K
Net Debt$9.75M$8.55M$8.1M$5.18M$8.69M$3.58M$3.47M$2.6M$1.69M$1.52M$2.04M$1.36M$1.21M$334K-$723K$49K-$123K$81K$169K-$203K-$47K$0$43K
Cash Flow Statement
PeriodFY 2025FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006FY 2005FY 2004FY 2003FY 2002FY 2001FY 2000
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
Operating Activities
Net Income-$2.05M$8.18M-$13.1M-$769K-$6.59M-$3.88M-$4.03M-$3.45M-$5.39M-$2.53M-$4.34M-$3.61M-$4.4M-$3.06M-$2.3M-$4.16M-$165K-$2.43M-$5.15M-$7.99M-$2.74M$89K-$184K-$2K
Depreciation & Amortization$101K$116K$63K$67K$77K$6K$6K$9K$11K$17K$15K$15K$16K$15K$6K$6K$23K$23K$37K$554K$107K-$117K$0$0
Deferred Income Tax$0$0$644K-$1.64M$816-$353K$14K$1.43M-$459K$223K$1.85M$958K$23K-$91K$0-$500K-$628K-$2.86M$43K$43K-$43K$0$0$0
Stock-Based Compensation$27K$21K$154K$9K$72K$0$74K$391K$2.74M$512K$1.39M$1.8M$854K$1.38M$613K$500K$605K$2.86M$2.87M$0$1.36M$0$0$0
Changes in Working Capital:
  Accounts Receivable-$126K$24K-$9K-$5K-$18K-$2K$15K-$9K$105K-$116K$27K-$38K$244K-$5K-$240K$0-$5K$39K$0$0$0$0$0$0
  Inventory$14K$26K-$46K-$24K-$25K-$15K$5K-$2K-$7K-$42K-$5K$118K$135K-$87K-$155K$655-$11K-$11K$0$0$0$0$0$0
  Accounts Payable$51K$55K$73K$10K$108K$87K$344K$462K$28K$559K$430K$169K$738K$606K-$52K-$39K-$5K$15K$127K$0$26K$0$0$0
  Other Working Capital$272K$877K$64K$325K$342K$384K$35K-$196K$469K$32K$74K-$163K$139K-$195K$114K$263K$31K-$22K$99K$0$76K$0$0$0
Total Working Capital Change$211K$927K$73K$304K$407K$453K$400K$255K$595K$432K$526K$86K$1.26M$320K-$333K$224K$9K$20K$226K$227K$101K$27K$0$0
Other Non-Cash Items$544K-$10M$10.42M$1.15M$5.29M$2.71M$2.4M$9K$1.48M$1.2M$31K$33K$360K$80K$59K$2.96M-$649K$651K$451K$5.65M$1.13M$0$134K$0
Net Cash from Operating-$1.16M-$762K-$1.74M-$878K-$744K-$1M-$1.14M-$1.36M-$1.02M-$148K-$531K-$721K-$1.89M-$1.36M-$1.96M-$976K-$805K-$1.74M-$1.53M-$1.51M-$79K-$6-$50K-$2K
Investing Activities
Capital Expenditures-$26K-$58K-$39K-$6K$0$0-$9K-$3K-$718-$22K$0$0-$1K-$72K-$8K$0$0-$10K-$29K$0$0$0$0$0
Acquisitions$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$40K$0$0$0-$57K$0$0$0$0
Purchases of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0-$130K-$105K$0$0$0$0
Sales of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Investing Activities-$25K$85K-$255K$0$0$0$0$0$0$0$0$0$0$0$0-$300K-$2K$0$0-$3K$3K$0$0$0
Net Cash from Investing-$51K$27K-$294K-$6K$0$0-$9K-$3K-$718-$22K$0$0-$1K-$72K-$8K-$260K-$2K-$10K-$159K-$165K$3K$0$0$0
Financing Activities
Debt Repaid-$725K-$808K-$2.13M-$834K-$569K-$1M-$1.12M-$1.23M-$519K-$196K-$290K-$713K-$364K-$355K---$238K-----
Common Stock Issuance$0$0$536K$0$12K$0$0$155K$786K$60K$140K$447K$1.55M$500K$3.1M$809K$120K$622K$1.11M$923K$0$0$25K$2K
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$113K-$164K$0$50K$175K$0$561K$0$786K$0$163K$455K$0$0$0$0$0$975K$0$812K$123K$0$0$0
Net Cash from Financing$1.19M$644K$2.13M$884K$744K$1M$1.12M$1.38M$1.01M$181K$528K$729K$1.89M$627K$2.72M$1.16M$911K$1.7M$1.35M$2.04M$123K$0$25K$2K
Forex Effect$0$0$0$0$0$0$1.15M$0$0$0$0$0$0$1.43M$0$0$0$0$0$0$76K$0$0$0
Net Change in Cash-$24K-$91K$91K$0$0$0$1.12M$24K-$9K$11K-$3K$8K$0$627K$752K-$72K$104K-$50K-$340K$362K$123K-$6-$25K$0
Supplementary Data
Operating Cash Flow-$1.16M-$762K-$1.74M-$878K-$744K-$1M-$1.14M-$1.36M-$1.02M-$148K-$531K-$721K-$1.89M-$1.36M-$1.96M-$976K-$805K-$1.74M-$1.53M-$1.51M-$79K-$6-$50K-$2K
Capital Expenditure-$26K-$58K-$39K-$6K$0$0-$9K-$3K-$718-$22K$0$0-$1K-$72K-$8K$0$0-$10K-$29K$0$0$0$0$0
Free Cash Flow-$1.19M-$820K-$1.78M-$884K-$744K-$1M-$1.15M-$1.36M-$1.02M-$170K-$531K-$721K-$1.89M-$1.43M-$1.96M-$976K-$805K-$1.75M-$1.56M-$1.51M-$79K-$6-$50K-$2K
Cash at Beginning$36K$91K$0$0$0$0$31K$7K$16K$5K$8K$0$0$803K$51K$123K$19K$69K$409K$47K-$76K$6$25K$0
Cash at End$12K$0$91K$0$0$0$1.15M$31K$7K$16K$5K$8K$0$1.43M$803K$51K$123K$19K$69K$409K$47K$0$6$0